Concepedia

Holger Klaproth

HK

Statistics

Publications

3

Citations

89

H-Index

3

Active since

2002

Affiliations

Praxis für Hämatologie und Onkologie(Current)

Universität Ulm

University of Cologne

Holger Klaproth is an author at Praxis für Hämatologie und Onkologie specializing in immunology, medicine, and oncology.

Top concepts

Publications per year

2002–2018

3

Publications

3

CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia

Julia von Tresckow, Paula Cramer, Jasmin Bahlo et al. · Leukemia · 2018 · 43 citations

, , +6

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

Christian Kollmannsberger, Oliver Rick, Holger Klaproth et al. · British Journal of Cancer · 2002 · 30 citations · Full text

CLL2-BIG - a Novel Treatment Regimen of Bendamustine Followed By GA101 and Ibrutinib Followed By Ibrutinib and GA101 Maintenance in Patients with Chronic Lymphocytic Leukemia (CLL): Interim Results of a Phase II-Trial

Julia von Tresckow, Paula Cramer, Jasmin Bahlo et al. · Blood · 2015 · 16 citations

1–3 of 3